Literature DB >> 22605857

Rosuvastatin-induced pemphigoid.

Aizuri A Murad1, Maureen Connolly, Anne-Marie Tobin.   

Abstract

Statins are widely prescribed medications and very well tolerated. Rosuvastatin is another member of this drug used to treat dyslipidaemia. It is a competitive inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase. Immunobullous disease is usually idiopathic but can be drug-induced. Both idiopathic and iatrogenic forms share common clinical and immunohistological features. The authors report a case of pemphigoid induced by rosuvastatin, a commonly prescribed medication. To our knowledge, there is limited report on rosuvastatin associated with pemphigoid in the literature.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605857      PMCID: PMC3351646          DOI: 10.1136/bcr.11.2011.5180

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

Review 1.  Pemphigus and bullous pemphigoid due to drugs.

Authors:  V Ruocco; G Sacerdoti
Journal:  Int J Dermatol       Date:  1991-05       Impact factor: 2.736

Review 2.  Bullous pemphigoid--an adverse effect of ampicillin.

Authors:  E Hodak; A Ben-Shetrit; A Ingber; M Sandbank
Journal:  Clin Exp Dermatol       Date:  1990-01       Impact factor: 3.470

3.  Bullous pemphigoid in an 11-year-old boy.

Authors:  S F Bean; R A Good; D B Windhorst
Journal:  Arch Dermatol       Date:  1970-08

4.  Bullous pemphigoid-like lesions induced by phenacetin. Report of a case and an immunopathologic study.

Authors:  M Kashihara; K Danno; Y Miyachi; Y Horiguchi; S Imamura
Journal:  Arch Dermatol       Date:  1984-09
  4 in total
  2 in total

1.  Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.

Authors:  Sian-De Liu; Wei-Ti Chen; Ching-Chi Chi
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

2.  A generalised sensation of coldness following introduction of rosuvastatin therapy.

Authors:  Niem Tu Huynh; Philippe Huot
Journal:  BMJ Case Rep       Date:  2014-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.